bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.08.03.668352

Genetic Insights of Image-Based Traits: Analysis Pipeline for AI-based Phenotyping, Combined-GWAS, and Federated Learning with Application to the Human Face

Abstract

Biological images capture rich morphological information and understanding their genetic basis is crucial for elucidating underlying molecular mechanisms, relevant in biomedical, evolutionary, and forensic research and applications. However, progress in understanding the genetic basis of image-based complex traits is hindered by key limitations in the current methodology, regarding both, the degree of which the large image complexity is captured with the phenotyping methods and how the analysis methods deal with the underlying large genetic complexity. Here, we present a robust, scalable, privacy-preserving computer pipeline for analysing image-based complex traits and unveiling their genetic basis by integrating (i) AI-based phenotyping for large-scale extraction of image-based traits across cohorts in a federated learning framework, without sharing individual images; (ii) Combined-GWAS (C-GWAS) for identifying genetic variants underlying the numerous AI-derived image-based traits; and (iii) Explainable AI (XAI)-based image visualization of the identified genetic association effects. In its first application to the example of the human face, we analysed 3D facial images and genomic data from two European cohorts (N=7,309), extracted 200 AI-derived facial traits, identified 43 significantly face associated genetic loci, including 12 novel ones, and replicated 70% of them in an independent European dataset (N=8,246). XAI-based visualization of the identified genetic effects shows the involvement of many of these loci in different parts of the face. Our study provides a privacy-aware and extensible pipeline for investigating the genetic basis of image-based complex traits implemented in a computationally efficient python package available at GitLab and its first application yielded new insights into the genetic architecture of facial shape variation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Liu, X., Xiong, Z., Liu, F., Nijsten, T., Wolvius, E. B., Kayser, M., Roshchupkin, G. V.. 2025-08-03. Genetic Insights of Image-Based Traits: Analysis Pipeline for AI-based Phenotyping, Combined-GWAS, and Federated Learning with Application to the Human Face. https://doi.org/10.1101/2025.08.03.668352

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗